Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic
暂无分享,去创建一个
M. Chung | A. Nowacki | N. Mehta | S. Kapadia | U. Khot | R. Puri | A. Kalra | Ashish Kumar | A. Jabri | G. Reed | A. Alameh | David P. Hedrick | Anmar Kanaa’n | R. Shah | Shameer Khubber | S. Adroja | H. Bashir | K. Sleik | Khaled M. Sleik
[1] T. Tabuchi,et al. Coronavirus Disease , 2021, Encyclopedia of the UN Sustainable Development Goals.
[2] M. Chung,et al. Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19). , 2020, JAMA cardiology.
[3] P. Bhargava,et al. Cardiac Tamponade Secondary to COVID-19 , 2020, JACC: Case Reports.
[4] C. Basso,et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection , 2020, European heart journal.
[5] L. Xia,et al. Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. , 2020, AJR. American journal of roentgenology.
[6] Jeroen J. Bax,et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology , 2018, European heart journal.
[7] D. Goldstein,et al. Takotsubo Cardiomyopathy: A New Form of Acute, Reversible Heart Failure , 2008, Circulation.
[8] A. Lerman,et al. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. , 2008, American heart journal.
[9] H. Schunkert,et al. Apical and midventricular transient left ventricular dysfunction syndrome (tako-tsubo cardiomyopathy): frequency, mechanisms, and prognosis. , 2007, Chest.
[10] PSYCHIATRIA DANUBINA , 2022 .